Concurrent whole brain radiotherapy and bortezomib for brain metastasis
Authors:
- Christopher D LaoCLChristopher D Lao
- Judah FriedmanJFJudah Friedman
- Christina I TsienCTChristina I Tsien
- Daniel P NormolleDNDaniel P Normolle
- Christopher ChapmanCCChristopher Chapman
- Yue CaoYCYue Cao
- Oliver LeeOLOliver Lee
- Matt SchipperMSMatt Schipper
- Catherine Van PoznakCPCatherine Van Poznak
- Daniel HamstraDHDaniel Hamstra
- Theodore LawrenceTLTheodore Lawrence
- James HaymanJHJames Hayman
Open Access
- 21 August 2013
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 204
Abstract
Survival of patients with brain metastasis particularly from historically more radio-resistant malignancies remains dismal. A phase I study of concurrent bortezomib and whole brain radiotherapy was conducted to determine the tolerance and safety of this approach in patients with previously untreated brain metastasis.Keywords
This publication has 25 references indexed in Scilit:
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trialThe Lancet Oncology, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 StudyJournal of Clinical Oncology, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Designing Dose-Escalation Trials With Late-Onset Toxicities Using the Time-to-Event Continual Reassessment MethodJournal of Clinical Oncology, 2006
- A phase II study of bortezomib in the treatment of metastatic malignant melanomaCancer, 2005
- Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working GroupJournal of Cancer Research and Clinical Oncology, 2002
- Molecular Pathways That Modify Tumor Radiation ResponseAmerican Journal of Clinical Oncology, 2001
- Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κBInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanomaJournal of Neurosurgery, 1998